Renaturation and purification of bone morphogenetic protein-2 produced as inclusion bodies in high-cell-density cultures of recombinant Escherichia coli

被引:131
作者
Vallejo, LF
Brokelmann, M
Marten, S
Trappe, S
Cabrera-Crespo, J
Hoffmann, A
Gross, G
Weich, HA
Rinas, U
机构
[1] Natl Res Ctr Biotechnol, GBF, Biochem Engn Div, D-38124 Braunschweig, Germany
[2] Natl Res Ctr Biotechnol, GBF, Div Mol Biol, D-38124 Braunschweig, Germany
基金
巴西圣保罗研究基金会;
关键词
rhBMP-2; E; coli; in vitro refolding; purification;
D O I
10.1016/S0168-1656(01)00425-4
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Eschericha coli was genetically engineered to produce recombinant human bone morphogenetic protein-2 (rhBMP-2) in a non-active aggregated form using a temperature-inducible expression system. High concentrations of both biomass (75 g cell dry weight per liter of culture broth) and inactive rhBMP-2 (8.6 g l(-1)) were obtained by applying a high-cell-density cultivation procedure. After washing and solubilizing the inclusion bodies, rhBMP-2 was refolded and dimerized at concentrations up to 100 mg l(-1) by means of a simple dilution method with yields exceeding 50%. Finally, a one-step purification procedure based on affinity chromatography was implemented to isolate the rhBMP-2 dimer. With the established renaturation and purification protocols, yields of more than 10 mg rhBMP-2 dimer per gram cell dry weight were obtained corresponding to 750 mg rhBMP-2 dimer per liter of culture broth. The purified rhBMP-2 dimer showed biological activity equivalent to CHO produced rhBMP-2 as tested by the induction of alkaline phosphatase activity in C2Cl2 cells. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:185 / 194
页数:10
相关论文
共 27 条
[1]   EXPRESSION OF HUMAN BONE MORPHOGENETIC PROTEINS-2 OR PROTEINS-4 IN MURINE MESENCHYMAL PROGENITOR C3H10T1/2 CELLS INDUCES DIFFERENTIATION INTO DISTINCT MESENCHYMAL CELL LINEAGES [J].
AHRENS, M ;
ANKENBAUER, T ;
SCHRODER, D ;
HOLLNAGEL, A ;
MAYER, H ;
GROSS, G .
DNA AND CELL BIOLOGY, 1993, 12 (10) :871-880
[2]   Production of interferon-α in high cell density cultures of recombinant Escherichia coli and its single step purification from refolded inclusion body proteins [J].
Babu, KR ;
Swaminathan, S ;
Marten, S ;
Khanna, N ;
Rinas, U .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2000, 53 (06) :655-660
[3]   Comparison of recombinant and purified human bone morphogenetic protein [J].
Bessho, K ;
Kusumoto, K ;
Fujimura, K ;
Konishi, Y ;
Ogawa, Y ;
Tani, Y ;
Iizuka, T .
BRITISH JOURNAL OF ORAL & MAXILLOFACIAL SURGERY, 1999, 37 (01) :2-5
[4]   The use of rhBMP-2 in interbody fusion cages - Definitive evidence of osteoinduction in humans: A preliminary report [J].
Boden, SD ;
Zdeblick, TA ;
Sandhu, HS ;
Heim, SE .
SPINE, 2000, 25 (03) :376-381
[5]  
CERLETTI N, 2000, Patent No. 6057430
[6]  
Cerletti N., 1991, European Patent Application, Patent No. 0433225
[7]   Three-dimensional structure of recombinant human osteogenic protein 1: Structural paradigm for the transforming growth factor beta superfamily [J].
Griffith, DL ;
Keck, PC ;
Sampath, TK ;
Rueger, DC ;
Carlson, WD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (02) :878-883
[8]  
HOFFMANN A, IN PRESS J CELL BIOL
[9]   Bone morphogenetic proteins: Multifunctional regulators of vertebrate development [J].
Hogan, BLM .
GENES & DEVELOPMENT, 1996, 10 (13) :1580-1594
[10]   Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo [J].
Israel, DI ;
Nove, J ;
Kerns, KM ;
Kaufman, RJ ;
Rosen, V ;
Cox, KA ;
Wozney, JM .
GROWTH FACTORS, 1996, 13 (3-4) :291-300